Table of Contents

2019-2024 Global Pharmaceutical Products and CMO Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Products and CMO Market Size 2014-2024
2.1.2 Pharmaceutical Products and CMO Market Size CAGR by Region
2.2 Pharmaceutical Products and CMO Segment by Type
2.2.1 Active Pharmaceutical Ingredient (API)
2.2.2 Finished Dosage Form (FDF)
2.2.3 Pharmaceutical Packaging
2.3 Pharmaceutical Products and CMO Market Size by Type
2.3.1 Global Pharmaceutical Products and CMO Market Size Market Share by Type (2014-2019)
2.3.2 Global Pharmaceutical Products and CMO Market Size Growth Rate by Type (2014-2019)
2.4 Pharmaceutical Products and CMO Segment by Application
2.4.1 Specialty/Midsize
2.4.2 Generics
2.4.3 Big Pharma
2.4.4 Others
2.5 Pharmaceutical Products and CMO Market Size by Application
2.5.1 Global Pharmaceutical Products and CMO Market Size Market Share by Application (2014-2019)
2.5.2 Global Pharmaceutical Products and CMO Market Size Growth Rate by Application (2014-2019)

3 Global Pharmaceutical Products and CMO by Players
3.1 Global Pharmaceutical Products and CMO Market Size Market Share by Players
3.1.1 Global Pharmaceutical Products and CMO Market Size by Players (2017-2019)
3.1.2 Global Pharmaceutical Products and CMO Market Size Market Share by Players (2017-2019)
3.2 Global Pharmaceutical Products and CMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers and Acquisitions, Expansion

4 Pharmaceutical Products and CMO by Regions
4.1 Pharmaceutical Products and CMO Market Size by Regions
4.2 Americas Pharmaceutical Products and CMO Market Size Growth
4.3 APAC Pharmaceutical Products and CMO Market Size Growth
4.4 Europe Pharmaceutical Products and CMO Market Size Growth
4.5 Middle East and Africa Pharmaceutical Products and CMO Market Size Growth

5 Americas
5.1 Americas Pharmaceutical Products and CMO Market Size by Countries
5.2 Americas Pharmaceutical Products and CMO Market Size by Type
5.3 Americas Pharmaceutical Products and CMO Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Pharmaceutical Products and CMO Market Size by Countries
6.2 APAC Pharmaceutical Products and CMO Market Size by Type
6.3 APAC Pharmaceutical Products and CMO Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Pharmaceutical Products and CMO by Countries
7.2 Europe Pharmaceutical Products and CMO Market Size by Type
7.3 Europe Pharmaceutical Products and CMO Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East and Africa
8.1 Middle East and Africa Pharmaceutical Products and CMO by Countries
8.2 Middle East and Africa Pharmaceutical Products and CMO Market Size by Type
8.3 Middle East and Africa Pharmaceutical Products and CMO Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Pharmaceutical Products and CMO Market Forecast
10.1 Global Pharmaceutical Products and CMO Market Size Forecast (2019-2024)
10.2 Global Pharmaceutical Products and CMO Forecast by Regions
10.2.1 Global Pharmaceutical Products and CMO Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East and Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East and Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Pharmaceutical Products and CMO Forecast by Type
10.8 Global Pharmaceutical Products and CMO Forecast by Application

11 Key Players Analysis
11.1 Catalent
11.1.1 Company Details
11.1.2 Pharmaceutical Products and CMO Product Offered
11.1.3 Catalent Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Catalent News
11.2 DPx
11.2.1 Company Details
11.2.2 Pharmaceutical Products and CMO Product Offered
11.2.3 DPx Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 DPx News
11.3 Lonza
11.3.1 Company Details
11.3.2 Pharmaceutical Products and CMO Product Offered
11.3.3 Lonza Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Lonza News
11.4 Piramal Healthcare
11.4.1 Company Details
11.4.2 Pharmaceutical Products and CMO Product Offered
11.4.3 Piramal Healthcare Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Piramal Healthcare News
11.5 Aenova
11.5.1 Company Details
11.5.2 Pharmaceutical Products and CMO Product Offered
11.5.3 Aenova Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Aenova News
11.6 Jubilant
11.6.1 Company Details
11.6.2 Pharmaceutical Products and CMO Product Offered
11.6.3 Jubilant Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Jubilant News
11.7 Famar
11.7.1 Company Details
11.7.2 Pharmaceutical Products and CMO Product Offered
11.7.3 Famar Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Famar News
11.8 Boehringer Ingelheim
11.8.1 Company Details
11.8.2 Pharmaceutical Products and CMO Product Offered
11.8.3 Boehringer Ingelheim Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Boehringer Ingelheim News
11.9 Fareva Holding
11.9.1 Company Details
11.9.2 Pharmaceutical Products and CMO Product Offered
11.9.3 Fareva Holding Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Fareva Holding News
11.10 AbbVie
11.10.1 Company Details
11.10.2 Pharmaceutical Products and CMO Product Offered
11.10.3 AbbVie Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 AbbVie News
11.11 Nipro Corp
11.12 Vetter
11.13 Sopharma
11.14 Mylan (DPT Laboratories)
11.15 Recipharm
11.16 NextPharma Technologies
11.17 Dishman
11.18 Aesica

12 Research Findings and Conclusion